Lighting Up Alpha-synuclein Oligomers

被引：2
|
作者：
Richter, Franziska [1 ]
机构：
[1] Univ Leipzig, Inst Pharmacol Pharm & Toxicol, Leipzig, Germany
来源：
EBIOMEDICINE | 2018年 / 29卷
关键词：
PARKINSONS-DISEASE; NEURODEGENERATION; PATHOLOGY; MICE;
D O I：
10.1016/j.ebiom.2018.02.016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [1] Alpha-synuclein oligomers: a new hope
    Bengoa-Vergniory, Nora
    Roberts, Rosalind F.
    Wade-Martins, Richard
    Alegre-Abarrategui, Javier
    ACTA NEUROPATHOLOGICA, 2017, 134 (06) : 819 - 838
  • [2] Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
    Dening, Yanina
    Strassl, Theresa
    Ruf, Viktoria
    Dirscherl, Petra
    Chovsepian, Alexandra
    Stievenard, Alicia
    Khairnar, Amit
    Schmidt, Felix
    Giesert, Florian
    Herms, Jochen
    Levin, Johannes
    Dieterich, Marianne
    Falkai, Peter
    Weisenhorn, Daniela Vogt
    Wurst, Wolfgang
    Giese, Armin
    Pan-Montojo, Francisco
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [3] Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers
    Vaikath, Nishant
    Sudhakaran, Indulekha
    Abdi, Ilham
    Gupta, Vijay
    Majbour, Nour
    Ghanem, Simona
    Abdesselem, Houari
    Vekrellis, Kostas
    El-Agnaf, Omar
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [4] Annular alpha-synuclein oligomers are potentially toxic agents in alpha-synucleinopathy. Hypothesis
    Dean L. Pountney
    Nicolas H. Voelcker
    Wei Ping Gai
    Neurotoxicity Research, 2005, 7 : 59 - 67
  • [5] Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells
    Shavali, Shaik
    Brown-Borg, Holly M.
    Ebadi, Manuchair
    Porter, James
    NEUROSCIENCE LETTERS, 2008, 439 (02) : 125 - 128
  • [6] Astrocytes and Alpha-Synuclein: Friend or Foe?
    Ozoran, Hakan
    Srinivasan, Rahul
    JOURNAL OF PARKINSONS DISEASE, 2023, 13 (08) : 1289 - 1301
  • [7] Annular alpha-synuclein oligomers are potentially toxic agents in alpha-synucleinopathy. Hypothesis.
    Pountney, DL
    Voelcker, NH
    Gai, WP
    NEUROTOXICITY RESEARCH, 2005, 7 (1-2) : 59 - 67
  • [8] Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers
    Dokleja, Lana
    Hannula, Mirva J.
    Myohanen, Timo T.
    NEUROSCIENCE LETTERS, 2014, 583 : 37 - 42
  • [9] Cardiac Alpha-Synuclein Is Present in Alpha-Synucleinopathies
    Javanshiri, Keivan
    Drakenberg, Tove
    Haglund, Mattias
    Englund, Elisabet
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (04) : 1125 - 1131
  • [10] Stabilization of Alpha-Synuclein Oligomers In Vitro by the Neurotransmitters, Dopamine and Norepinephrine: The Effect of Oxidized Catecholamines
    Fischer, Andrew F.
    Matera, Kathryn Mansfield
    NEUROCHEMICAL RESEARCH, 2015, 40 (07) : 1341 - 1349
12345